Literature DB >> 2360794

Antibody response to rubella virus structural proteins in multiple sclerosis.

A Nath1, J S Wolinsky.   

Abstract

The antibody response to the structural proteins of rubella virus was studied in patients with multiple sclerosis (MS). Irrespective of the antibody titer to whole rubella virus, the relative proportion of the IgG response to the surface glycoprotein E1 was diminished, and that to the surface glycoprotein E2 was elevated in MS patients when compared to a matched control population of normal health individuals or a group of patients with systemic lupus erythematosus and other collagen vascular diseases. No difference was observed in the response to the core protein of rubella virus on comparing the MS and normal control groups. This divergence in the relative antibody response to the viral surface proteins suggests that the vigorous antibody response to rubella virus reported in MS is not simply an expression of a nonspecific polyvalent B-cell response.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2360794     DOI: 10.1002/ana.410270513

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  7 in total

1.  Characterization of a novel binding site for the human immunodeficiency virus type 1 envelope protein gp120 on human fetal astrocytes.

Authors:  M Ma; J D Geiger; A Nath
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

2.  Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development.

Authors:  Avindra Nath; Elizabeth Hall; Marnia Tuzova; Michael Dobbs; Melina Jons; Caroline Anderson; Jerold Woodward; Zhihong Guo; Weiming Fu; Richard Kryscio; David Wekstein; Charles Smith; William R Markesbery; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

3.  Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides.

Authors:  M McCarthy; A Lovett; R H Kerman; A Overstreet; J S Wolinsky
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

Review 4.  Transient virus infection and multiple sclerosis.

Authors:  G J Atkins; S McQuaid; M M Morris-Downes; S E Galbraith; S Amor; S L Cosby; B J Sheahan
Journal:  Rev Med Virol       Date:  2000 Sep-Oct       Impact factor: 6.989

5.  Multiplication of rubella and measles viruses in primary rat neural cell cultures: relevance to a postulated triggering mechanism for multiple sclerosis.

Authors:  G J Atkins; D A Mooney; D A Fahy; S H Ng; B J Sheahan
Journal:  Neuropathol Appl Neurobiol       Date:  1991-08       Impact factor: 8.090

Review 6.  Infections and multiple sclerosis.

Authors:  Arun Venkatesan; Richard T Johnson
Journal:  Handb Clin Neurol       Date:  2014

Review 7.  Molecular biology of rubella virus.

Authors:  T K Frey
Journal:  Adv Virus Res       Date:  1994       Impact factor: 9.937

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.